Kunming Longjin Pharmaceutical News

Review of Longjin Pharmaceutical (002750): Consolidating leading position under the dual pronged approach of R&D and marketing, strong second shareholder strength helps the company grow

銀河證券Dec 1, 2015 00:00

[Galaxy Securities] Long John Pharmaceutical: research and development + marketing to consolidate the leading position, the two shareholders are strong to promote the growth of the company

銀河證券Nov 30, 2015 00:00

[Hengtai Securities] Long John Pharmaceutical: the pressure level at the initial stage of listing is expected to be 52-56 yuan

恆泰證券Mar 12, 2015 00:00

[Shanghai Securities] Longjin Pharmaceutical: Professional manufacturer of lyophilized powder needles for injectable dengzendron

上海證券Mar 12, 2015 00:00

[Huatai] Long John Pharmaceutical: recommended purchase on March 12th

華泰證券Mar 11, 2015 00:00

Long John Pharmaceutical (002750) New share purchase Strategy

華泰證券Mar 11, 2015 00:00

[northeast Securities] Long John Pharmaceutical IPO pricing report: characteristic traditional Chinese Medicine injection Enterprises

東北證券Mar 9, 2015 00:00